Ibis celebrates the first-ever application for an OTC birth control pill in the United States

Ibis announces new partnership with AMAZE.org in the Africa region

Celebrating 20 years of impact: A visual chronicle of Ibis's history

Announcing the launch of Ibis's Africa Region Strategy for 2022-2025

Check out findings from the Trust Black Women study, conducted in partnership with SisterSong

Home

Evidence, Power, and Change drive our vision:

An inclusive, just world where we all exercise our human right to a pleasurable, safe, and healthy sexual and reproductive life.

#IbisDrivesChange

Recent Publications

November 2022

Pilot label comprehension study for an over-the-counter combined oral contraceptive pill in the United States

November 2022

Interest in continued use after participation in a study of over-the-counter progestin-only pills in the United States

October 2022

Inter-departmental abortion travels in metropolitan France: A mixed-methods analysis of women’s experiences, access, and barriers to abortion care

News & Announcements

October 2022

Ibis responds to FDA’s announcement to postpone advisory committee meeting for over-the-counter birth control pill

August 2022

New partnership will expand access to comprehensive sexuality education resources in Africa

July 2022

New survey reveals difficulties accessing abortion in Indiana, foreshadows worsening harms now that Roe v. Wade is overturned

Copyright © 2022 Ibis Reproductive Health. All rights reserved. Conflict of Interest Policy